相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of lipoic acid in multiple sclerosis
Hongsheng Xie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2022)
Effects of respiratory physiotherapy in patients with amyotrophic lateral sclerosis: protocol for a systematic review of randomised controlled trials
Karen Pondofe et al.
BMJ OPEN (2022)
The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis
Peter G. E. Kennedy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta-Analysis
Alex Medina et al.
MOVEMENT DISORDERS (2022)
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease
Yumin Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review
Welayah Ali AlAmmar et al.
NUTRITIONAL NEUROSCIENCE (2021)
Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action
Pei Teng Lum et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Emerging potential of cannabidiol in reversing proteinopathies
Raju Dash et al.
AGEING RESEARCH REVIEWS (2021)
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
Rosalba Leuci et al.
FOODS (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson's Disease: A Single-Center, Randomized, Placebo-Controlled Trial
Chandramohan Wakade et al.
BIOMEDICINES (2021)
Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study
Katharina Klumbies et al.
FRONTIERS IN NEUROLOGY (2021)
The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients
Jose Luis Platero et al.
LIFE-BASEL (2021)
Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study
Jose Enrique de la Rubia Orti et al.
NUTRIENTS (2021)
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial
Maria Petracca et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Phenylpropanoids and its derivatives: biological activities and its role in food, pharmaceutical and cosmetic industries
Neelam et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis
Martin Tolar et al.
ALZHEIMERS & DEMENTIA (2020)
Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death
Yong Qi Leong et al.
METABOLIC BRAIN DISEASE (2020)
The role of melatonin in Multiple Sclerosis
Charalampos Skarlis et al.
NEUROLOGICAL SCIENCES (2020)
Gastrointestinal Tolerability and Absorption of R- Versus R,S-Lipoic Acid in Progressive Multiple Sclerosis: A Randomized Crossover Trial
Michelle Cameron et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Nanoparticle-hydrogel superstructures for biomedical applications
Yao Jiang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
Julia Feige et al.
NUTRIENTS (2020)
Biosynthesis of aromatic polyketides in microorganisms using type II polyketide synthases
Jia Wang et al.
MICROBIAL CELL FACTORIES (2020)
Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum
Neha Milind Chitre et al.
NEUROPHARMACOLOGY (2020)
Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study
Po-Chih Chen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease
R. G. R. Pinheiro et al.
PHARMACEUTICAL RESEARCH (2020)
Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson's Disease: A Review
Dicson Sheeja Malar et al.
MOLECULES (2020)
Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study
Maria Benlloch et al.
NUTRIENTS (2020)
Caffeine and Parkinson's Disease: Multiple Benefits and Emerging Mechanisms
Xiangpeng Ren et al.
FRONTIERS IN NEUROSCIENCE (2020)
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Maureen A. Leehey et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study
Raul Juntas-Morales et al.
ECLINICALMEDICINE (2020)
Natural products: Potential therapeutic agents in multiple sclerosis
Shuangwen Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Benefits of Vitamins in the Treatment of Parkinson's Disease
Xiuzhen Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
The effect of exercise, yoga and physiotherapy on the quality of life of people with multiple sclerosis: Systematic review and meta-analysis
Khrisha B. Alphonsus et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2019)
Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis
Carin Waslo et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stephanie Andrade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis
Abraham Lieberman et al.
FRONTIERS IN NEUROLOGY (2019)
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Elisa Longinetti et al.
CURRENT OPINION IN NEUROLOGY (2019)
Parkinson's Disease: Clinical Review and Update
Veronica Cabreira et al.
ACTA MEDICA PORTUGUESA (2019)
The rights of precision drug development for Alzheimer's disease
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
William Camu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Martin R. Farlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets
Negar Ghanaatian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis
Berzenn Urbi et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies
Piyoosh Sharma et al.
PROGRESS IN NEUROBIOLOGY (2019)
Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Celeste Silveira et al.
PSYCHIATRY INVESTIGATION (2019)
Cognitive symptoms of Alzheimer's disease: clinical management and prevention
Elizabeth Joe et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects
Sarah E. Fiedler et al.
MOLECULAR NEUROBIOLOGY (2018)
Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease
Maria Morello et al.
MOLECULAR NEUROBIOLOGY (2018)
The efficacy and safety of memantine for the treatment of Alzheimer's disease
Shinji Matsunaga et al.
EXPERT OPINION ON DRUG SAFETY (2018)
A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
Amie L. Hiller et al.
PLOS ONE (2018)
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models
Luana Naia et al.
MOLECULAR NEUROBIOLOGY (2017)
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation
Marcus O. W. Grimm et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD) A randomized trial
Ronald B. Postuma et al.
NEUROLOGY (2017)
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease
Yufang Guo et al.
NEUROREPORT (2017)
Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells
Xiaping He et al.
FRONTIERS IN NEUROSCIENCE (2017)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
Nature Reviews Disease Primers (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Lipoic acid in secondary progressive MS A randomized controlled pilot trial
Rebecca Spain et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind
Roberta Ricciarelli et al.
CURRENT NEUROPHARMACOLOGY (2017)
Natural Products Combating Neurodegeneration: Parkinson's Disease
Md. Solayman et al.
CURRENT DRUG METABOLISM (2017)
Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons
Adrianne S. Chesser et al.
NUTRITIONAL NEUROSCIENCE (2016)
Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
U. Damar et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy
Laura C. Bott et al.
HUMAN MOLECULAR GENETICS (2016)
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis
Ahmad Reza Dorosty-Motlagh et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
Jose Luis Lopez-Sendon Moreno et al.
JOURNAL OF NEUROLOGY (2016)
Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
U. Damar et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease
Zun-Jing Liu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease
L. M. Schrott et al.
CURRENT ALZHEIMER RESEARCH (2015)
Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Seyed F. Nabavi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells
Jiraporn Panmanee et al.
JOURNAL OF PINEAL RESEARCH (2015)
Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis
Ken Ikeda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Potential Environmental Factors in Amyotrophic Lateral Sclerosis
Bjoern Oskarsson et al.
NEUROLOGIC CLINICS (2015)
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R. Scott Turner et al.
NEUROLOGY (2015)
The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
Heike J. Wobst et al.
FEBS LETTERS (2015)
Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model
Jennifer M. Walker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial
Maurice W. Dysken et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies
Joana A. Loureiro et al.
NANOMEDICINE (2014)
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial
Mohammad Khalili et al.
NUTRITIONAL NEUROSCIENCE (2014)
Marine natural products: Bryostatins in preclinical and clinical studies
Peter Kollar et al.
PHARMACEUTICAL BIOLOGY (2014)
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit
M. Flint Beal et al.
JAMA NEUROLOGY (2014)
Antioxidants for Alzheimer Disease A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas R. Galasko et al.
ARCHIVES OF NEUROLOGY (2012)
Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease: A Pre-Post Pilot Study
Cedric Annweiler et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2012)
Effects of Exercise and B Vitamins on Homocysteine and Glutathione in Parkinson's Disease: A Randomized Trial
Joanne DiFrancisco-Donoghue et al.
NEURODEGENERATIVE DISEASES (2012)
Caffeine for treatment of Parkinson disease A randomized controlled trial
Ronald B. Postuma et al.
NEUROLOGY (2012)
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
John M. Ringman et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Paul S. Aisen et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2011)
A phase II trial of huperzine A in mild to moderate Alzheimer disease
M. S. Rafii et al.
NEUROLOGY (2011)
Huntington's Disease
Steven Finkbeiner
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease A Randomized Trial
Joseph F. Quinn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Multiple roles for nicotine in Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Mechanism of docosahexaenoic acid-induced inhibition of in vitro Aβ1-42 fibrillation and Aβ1-42-induced toxicity in SH-S5Y5 cells
Shahdat Hossain et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study
S. Gauthier et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
A randomized, double-blind, placebo-controlled, delayed start study to assess safty, tolerability and efficacy of green tea polyphenols in Parkinson's disease
P. Chan et al.
PARKINSONISM & RELATED DISORDERS (2009)
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease - A randomized controlled trial
Paul S. Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease
Larry Baum et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Zhiming Yang et al.
NATURE MEDICINE (2007)
Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model
JoAnne McLaurin et al.
NATURE MEDICINE (2006)
Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides
P Marambaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
R Etcheberrigaray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Early Vitamin E supplementation in young but not aged mice reduces A beta levels and amyloid deposition in a transgenic model of Alzheimer's disease
S Sung et al.
FASEB JOURNAL (2003)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
分享论文
